Bio-Rad Laboratories (BIO) Net Cash Flow Growth (5y) (2014 - 2026)
Bio-Rad Laboratories (BIO) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Bio-Rad Laboratories | 8.61 Bn | 7.04 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.37% |
| Dec 31, 2025 | 22.12% |
| Sep 30, 2025 | -35.47% |
| Jun 30, 2025 | -201.40% |
| Mar 31, 2025 | 22.22% |
| Dec 31, 2024 | -6.37% |
| Sep 30, 2024 | 23.00% |
| Jun 30, 2024 | -17.50% |
| Mar 31, 2024 | 3.62% |
| Dec 31, 2023 | -75.88% |
| Sep 30, 2023 | 15.02% |
| Jun 30, 2023 | -57.31% |
| Mar 31, 2023 | 5.89% |
| Dec 31, 2022 | -25.35% |
| Sep 30, 2022 | -58.39% |
| Jun 30, 2022 | -60.95% |
| Mar 31, 2022 | 31.66% |
| Dec 31, 2021 | -59.30% |
| Sep 30, 2021 | 162.28% |
| Jun 30, 2021 | 22.53% |